@PharmPtEngage@JAPhAJournal Thanks for your question! You can find JAPhA's author guide here: https://t.co/Xw1BmoGndI
Scroll to the Visual Abstract section where you can read about our process and download our template
Let's get creative! Submit your next manuscript along with a visual abstract that you can create using our new template developed by @DougLaschRx to boost social media traction and readership!
#TwitteRx#pharmacists
10.1016/j.japh.2021.11.026
Had a fun time recording a podcast with @DougLaschRx yesterday, on the last day of his APPE rotation at @ASHPOfficial. Stay tuned for its release to hear what we talked about, #TwitteRx!😊
- Rounded alone for the first time ever two weeks into my onc rotation
- Responded to a code from a coworker fainting in the hall
- Sat in on a lumbar puncture (and nearly fainted, myself)
Just a typical Monday.
#APPEs#TwitteRx
@MeganByrne_Rx Love that goal! Some of my favorites:
- Leadership and Self-Deception (Did we read together at JH?)
- White Fragility
- To Shake the Sleeping Self
- Atomic Habits
- Range (currently reading, so far so good)
Bad habits reduction challenge inspired by #AtomicHabits [great book, would recommend]
Having a friend change my passwords for Facebook, Instagram and *sigh* Tik Tok; he will give me the new ones on Friday #quitscrolling#positivechange
We are excited to announce a call for papers in the area of #vaccine confidence and hesitancy. General author guidelines are at https://t.co/gu3aChG2LN. Submit your papers at https://t.co/mGO79AjnK8 Looking forward to some great submissions in this important area!
Today, I finished my very last OSCE ever! Surreal that the didactic portion of pharmacy school is coming to an end. Looking forward to my final year rotations and #residency
WOW 😳 New HIV vaccine with a 97% antibody response rate in phase I human trials. This is the most effective trial HIV vaccine to date. It is based on the Moderna's COVID vaccine. COVID tech acceleration could change Rx for cancer & HIV in future. https://t.co/3Nl0UJj6xW
IN PRESS: The authors describe faster approvals and quicker treatment initiation when prior authorizations are managed by a community-based specialty pharmacy versus a provider office. @Bradybot719@UNCPharmacy#communitypharmacy#TwitteRx#pharmacists
https://t.co/32w5UlYEnX